Stéphane Marot
Stéphane Marot
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,✉,#,
Isabelle Malet
Isabelle Malet
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,#,
Valentin Leducq
Valentin Leducq
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,
Karen Zafilaza
Karen Zafilaza
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,
Delphine Sterlin
Delphine Sterlin
2Sorbonne Université, INSERM, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), AP-HP, Pitié Salpêtrière Hospital, Department of Immunology, Paris, France
2,
Delphine Planas
Delphine Planas
3Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569 Paris, France
4Vaccine Research Institute, Creteil, France
3,4,
Adélie Gothland
Adélie Gothland
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,
Aude Jary
Aude Jary
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,
Karim Dorgham
Karim Dorgham
2Sorbonne Université, INSERM, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), AP-HP, Pitié Salpêtrière Hospital, Department of Immunology, Paris, France
2,
Timothée Bruel
Timothée Bruel
3Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569 Paris, France
4Vaccine Research Institute, Creteil, France
3,4;
the Sorbonne Université SARS-CoV-2 Neutralizing Antibodies Study Group,
Sonia Burrel
Sonia Burrel
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,
David Boutolleau
David Boutolleau
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,
Olivier Schwartz
Olivier Schwartz
3Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569 Paris, France
4Vaccine Research Institute, Creteil, France
3,4,
Guy Gorochov
Guy Gorochov
2Sorbonne Université, INSERM, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), AP-HP, Pitié Salpêtrière Hospital, Department of Immunology, Paris, France
2,
Vincent Calvez
Vincent Calvez
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1,
Anne-Geneviève Marcelin
Anne-Geneviève Marcelin
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
1
1Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
2Sorbonne Université, INSERM, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), AP-HP, Pitié Salpêtrière Hospital, Department of Immunology, Paris, France
3Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569 Paris, France
4Vaccine Research Institute, Creteil, France
5Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Pitié Salpêtrière Hospital, Paris, France
Subject terms: Viral infection, SARS-CoV-2, Viral infection
© The Author(s) 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
